# Lipoxygenase **Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/lipoxygenase **Data Source:** Hermetica Superfoods Ingredient Encyclopedia **Updated:** 2026-03-15 **Evidence Score:** 4 / 10 **Category:** Enzyme **Also Known As:** LOX, EC 1.13.11.x, EC 1.13.11.- ## Overview Lipoxygenases (LOX) are a family of non-heme iron-containing enzymes that catalyze the dioxygenation of polyunsaturated fatty acids like arachidonic acid. This process forms hydroperoxy derivatives, such as HPETEs, which are precursors to bioactive signaling molecules like pro-inflammatory leukotrienes and [anti-inflammatory](/ingredients/condition/inflammation) lipoxins. ## Health Benefits - Modulates inflammatory responses by catalyzing the biosynthesis of pro-inflammatory leukotrienes and [anti-inflammatory](/ingredients/condition/inflammation) lipoxins. - Influences immune cell function by regulating lipid mediator production, impacting leukocyte activity and immune cascades. - Plays a critical role in respiratory health by contributing to airway constriction mechanisms implicated in asthma and allergic reactions. - Impacts [cardiovascular health](/ingredients/condition/heart-health) through its involvement in vascular inflammation and endothelial cell signaling pathways. - Contributes to [skin health](/ingredients/condition/skin-health) by modulating localized inflammatory reactions associated with conditions like acne and dermatitis. ## Mechanism of Action Lipoxygenase enzymes catalyze the insertion of molecular oxygen into the cis,cis-1,4-pentadiene system of polyunsaturated fatty acids, including arachidonic and linoleic acid. This reaction generates hydroperoxy derivatives (e.g., hydroperoxyeicosatetraenoic acids, HPETEs). These HPETEs serve as crucial precursors for the biosynthesis of various bioactive signaling molecules, such as pro-inflammatory leukotrienes (via the 5-LOX pathway) and [anti-inflammatory](/ingredients/condition/inflammation) lipoxins, as well as 12S-hydroxyeicosatetraenoic acid (12-HETE) from the 12-LOX pathway. ## Clinical Summary Extensive peer-reviewed research, encompassing in vitro, animal, and human observational studies, has robustly documented lipoxygenase's central role in [inflammatory pathway](/ingredients/condition/inflammation)s. These studies have linked LOX activity to conditions such as asthma, cancer biology, and atherosclerosis. While specific sample sizes are not uniformly reported across this broad body of literature, the consistent findings underscore that the enzyme's inhibition has emerged as a significant therapeutic target in drug development for these diseases. ## Nutritional Profile - Non-heme iron-containing enzyme - Substrate specificity: Polyunsaturated fatty acids, particularly arachidonic acid, linoleic acid - Catalytic activity: Oxygenation of fatty acids to hydroperoxides ## Dosage & Preparation - Endogenous enzyme: Primarily expressed in various mammalian cells, including leukocytes, platelets, and epithelial cells. - Not available as a direct dietary supplement; its activity is modulated through dietary intake of fatty acids or pharmacological inhibitors. - Research applications: Focuses on understanding its role in disease pathways and developing targeted inhibitors for [inflammatory](/ingredients/condition/inflammation) conditions. ## Safety & Drug Interactions Information regarding specific side effects, drug interactions, contraindications, or safety during pregnancy related to Lipoxygenase as an enzyme entity is not available in the provided research. Clinical safety profiles would typically pertain to agents that modulate LOX activity, not the enzyme itself. Therefore, specific recommendations for human consumption or therapeutic use cannot be provided based on the given data. ## Scientific Research Extensive peer-reviewed research, including in vitro, animal, and human observational studies, has thoroughly documented lipoxygenase's central role in [inflammatory pathway](/ingredients/condition/inflammation)s, asthma, cancer biology, and atherosclerosis. The enzyme's inhibition has become a significant therapeutic target in drug development for conditions such as asthma, inflammatory bowel disease, and various dermatologic disorders. ## Historical & Cultural Context While lipoxygenase itself is a modern biochemical discovery, its physiological roles in [inflammation](/ingredients/condition/inflammation) and immune regulation resonate with ancient medical philosophies. Traditional systems like Ayurveda (e.g., managing excess “Pitta”) and Traditional Chinese Medicine (e.g., addressing “heat” and “dampness” syndromes) have long focused on balancing internal responses that modern science now links to lipid mediator pathways. ## Synergistic Combinations Role: Polyphenol/[antioxidant](/ingredients/condition/antioxidant) base Intention: Immune & [Inflammation](/ingredients/condition/inflammation) | Cardio & Circulation Primary Pairings: - Omega-3 Fatty Acids (EPA/DHA) - Curcumin (Curcuma longa) - Boswellia serrata - Quercetin (Sophora japonica) ## Frequently Asked Questions ### What is Lipoxygenase? Lipoxygenase (LOX) is a family of non-heme iron-containing oxidative enzymes found in plants, animals, and human tissues. It plays a fundamental role in the metabolism of polyunsaturated fatty acids. ### What is the primary mechanism of action for Lipoxygenase? LOX enzymes catalyze the dioxygenation of polyunsaturated fatty acids, such as arachidonic acid and linoleic acid. This initial step forms hydroperoxy derivatives, which then serve as precursors for a range of bioactive signaling molecules. ### How does Lipoxygenase influence health and disease? Lipoxygenase modulates inflammatory responses by producing pro-inflammatory leukotrienes and anti-inflammatory lipoxins, influencing immune cell function. Its activity is critically implicated in inflammatory pathways, asthma, cancer biology, and atherosclerosis, making its inhibition a therapeutic target. ### Which key compounds are produced through Lipoxygenase pathways? Key compounds produced include hydroperoxyeicosatetraenoic acids (HPETEs), which are precursors to leukotrienes (e.g., from 5-LOX activity), and lipoxins. The 12-LOX pathway specifically yields 12S-hydroxyeicosatetraenoic acid (12-HETE), among other epoxy/hydroxyl derivatives. ### Why is Lipoxygenase considered a significant therapeutic target? Lipoxygenase is considered a significant therapeutic target due to its central role in synthesizing potent lipid mediators that drive inflammation and immune responses. Its involvement in conditions like asthma, cancer, and atherosclerosis suggests that modulating LOX activity can offer therapeutic benefits. ### Does Lipoxygenase supplementation interact with asthma medications like bronchodilators or corticosteroids? Lipoxygenase inhibitors are sometimes used alongside conventional asthma treatments, but direct supplementation with Lipoxygenase enzyme itself is not a standard medical practice. Since Lipoxygenase enzymes are naturally produced in the body and regulate leukotriene production, supplementing with the enzyme could theoretically potentiate effects of asthma medications that also target leukotrienes. Anyone with asthma taking prescription medications should consult a healthcare provider before using Lipoxygenase-targeted supplements to avoid unintended interactions. ### Who should consider Lipoxygenase-targeting supplements, and who should avoid them? Individuals with inflammatory conditions, asthma, allergies, or chronic immune dysregulation may benefit from Lipoxygenase inhibitors or modulators rather than the enzyme itself. Those with bleeding disorders, on anticoagulant medications, or pregnant or nursing should avoid Lipoxygenase-modulating supplements without medical guidance, as these compounds affect immune and inflammatory pathways critical during these conditions. People with acute infections or compromised immune function should also exercise caution, as Lipoxygenase regulates immune cell activity. ### What clinical evidence exists for Lipoxygenase inhibitors versus direct enzyme supplementation? Substantial research supports Lipoxygenase inhibitors (not direct enzyme supplementation) for managing asthma, allergies, and inflammatory diseases by reducing leukotriene production. Clinical trials have demonstrated that selective Lipoxygenase inhibitors improve airway function and reduce allergic responses in asthmatic patients. Direct Lipoxygenase enzyme supplementation is not a established therapeutic approach, as the body naturally produces sufficient enzyme; evidence-based interventions target Lipoxygenase inhibition or modulation rather than enzyme replacement. ## References PubMed inflammatory enzyme studies; Journal of Lipid Research; NIH inflammatory pathway reviews --- *Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com* *License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*